Surgical Gastroenterologist Dr Anshuman Kaushal from Apollo Hospital has warned that persistent acidity and heartburn may ...

Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.

Thanksgiving is now only a few days away, and while it may feel good to fill your belly, overdoing it can cause some health ...

However, GERD is much more serious. It’s a chronic condition that typically includes symptoms like burning of the chest, ...

EoE is increasingly diagnosed in Europe, yet for many patients, the biggest hurdle lies beyond treating the inflammation.

Trinity St James's Cancer Institute (TSJCI) researchers demonstrated the power of a structured, quality-assured Barrett's Esophagus Registry to prevent and detect early esophageal cancer.

This prospective, observational, cohort study was conducted as part of a multicenter collaboration within the African Esophageal Cancer Consortium (ClinicalTrials.gov identifier: NCT05177393).

James Hamilton, MD, is the interim director of gastroenterology and hepatology and director of hepatology at Johns Hopkins Medicine. He also serves as an associate professor of medicine and of ...

"Gastroesophageal Reflux Disease (GERD) Market"The market for Gastroesophageal Reflux Disease (GERD) is poised for growth during the forecast period (2024-2034), due to escalating prevalence, aging ...

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces that the American ...

Managing editor Jack O’Brien talks with Lucid Diagnostics’ chief technology and compliance officer Dr. Brian deGuzman about the company’s nationwide initiative to provide education and testing for ...

Celldex Therapeutics said it wouldn't advance the development of a treatment for an inflammatory disease of the esophagus after the antibody failed to improve symptoms in a recent study. The company ...